<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/amersham-united-kingdom/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/amersham-united-kingdom</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Fri, 24 Apr 2026 17:45:02 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions]]></title>
		<link>https://www.thaipr.net/en/health_en/3079671</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 27 Jul 2021 13:30:28 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3079671</guid>

					<description><![CDATA[<p>&#8212; Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. &#8212; New sites opening in US and UK to realize regional manufacturing models. Overall, the companies plan to hire 2000 full-time associates over the next two years. &#8212; Investment follows five strategic [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3079671">Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index]]></title>
		<link>https://www.thaipr.net/en/general_en/3035904</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 09 Mar 2021 14:00:00 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3035904</guid>

					<description><![CDATA[<p>&#8211; A survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&#38;D ecosystem, manufacturing agility, and government policy and regulation &#8211; There is a strong correlation between higher performing countries and higher income per capita; United [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3035904">Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator]]></title>
		<link>https://www.thaipr.net/en/general_en/3024157</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 01 Feb 2021 13:00:00 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3024157</guid>

					<description><![CDATA[<p>&#8211; Cytiva will now provide &#8220;idea to injection&#8221; solutions to customers and the market &#8211; Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies &#8211; First acquisition by company since becoming Cytiva in April 2020 Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3024157">Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Cytiva delivers modular biologics factory to Lonza]]></title>
		<link>https://www.thaipr.net/en/general_en/3018738</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 14 Jan 2021 14:30:02 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3018738</guid>

					<description><![CDATA[<p>&#8211; From site selection in Guangzhou Biopark to handover during the global pandemic, 17,000-square meter site was completed in less than two years&#8211; From Lonza&#8217;s first manufacturing site for biologics in China, the healthcare leader will provide services and manufacturing needed to respond to growing global pharmaceutical needs&#8211; Site to become a strategic base in [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3018738">Cytiva delivers modular biologics factory to Lonza</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
